title: Reduction of HIV-associated oral lesions after highly active antiretroviral therapy.
authors.forename: J M
authors.initials: JM
authors.lastname: Aguirre
authors.forename: M A
authors.initials: MA
authors.lastname: Echebarria
authors.forename: E
authors.initials: E
authors.lastname: Ocina
authors.forename: L
authors.initials: L
authors.lastname: Ribacoba
authors.forename: M
authors.initials: M
authors.lastname: Montejo
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D008297:Male; D009059:Mouth Diseases / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors